198 related articles for article (PubMed ID: 15027998)
21. Effects of exposure imprecision on estimation of the benchmark dose.
Budtz-Jørgensen E; Keiding N; Grandjean P
Risk Anal; 2004 Dec; 24(6):1689-96. PubMed ID: 15660622
[TBL] [Abstract][Full Text] [Related]
22. Parameters of a dose-response model are on the boundary: what happens with BMDL?
Kopylev L; Fox J
Risk Anal; 2009 Jan; 29(1):18-25. PubMed ID: 18808395
[TBL] [Abstract][Full Text] [Related]
23. Likelihood-based confidence intervals for a log-normal mean.
Wu J; Wong AC; Jiang G
Stat Med; 2003 Jun; 22(11):1849-60. PubMed ID: 12754720
[TBL] [Abstract][Full Text] [Related]
24. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
Kuljus K; von Rosen D; Sand S; Victorin K
Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
[TBL] [Abstract][Full Text] [Related]
25. [Quantitative methods of cancer risk assessment in exposure to chemicals].
Szymczak W
Med Pr; 2009; 60(3):215-21. PubMed ID: 19746890
[TBL] [Abstract][Full Text] [Related]
26. Model averaging using fractional polynomials to estimate a safe level of exposure.
Faes C; Aerts M; Geys H; Molenberghs G
Risk Anal; 2007 Feb; 27(1):111-23. PubMed ID: 17362404
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.
Carr GJ; Portier CJ
Biometrics; 1993 Sep; 49(3):779-91. PubMed ID: 8241373
[TBL] [Abstract][Full Text] [Related]
28. The use of benchmark dose methodology with acute inhalation lethality data.
Fowles JR; Alexeeff GV; Dodge D
Regul Toxicol Pharmacol; 1999 Jun; 29(3):262-78. PubMed ID: 10388612
[TBL] [Abstract][Full Text] [Related]
29. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
30. A new model function for continuous data sets in health risk assessment of chemicals using the benchmark dose concept.
Kalliomaa K; Haag-Grönlund M; Victorin K
Regul Toxicol Pharmacol; 1998 Apr; 27(2):98-107. PubMed ID: 9671564
[TBL] [Abstract][Full Text] [Related]
31. Order-restricted dose-related trend tests.
Mancuso JY; Ahn H; Chen JJ
Stat Med; 2001 Aug; 20(15):2305-18. PubMed ID: 11468765
[TBL] [Abstract][Full Text] [Related]
32. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.
Sand S; von Rosen D; Victorin K; Filipsson AF
Toxicol Sci; 2006 Mar; 90(1):241-51. PubMed ID: 16322076
[TBL] [Abstract][Full Text] [Related]
33. Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation.
Wheeler MW; Bailer AJ
Risk Anal; 2007 Jun; 27(3):659-70. PubMed ID: 17640214
[TBL] [Abstract][Full Text] [Related]
34. A statistical test of compatibility of data sets to a common dose-response model.
Stiteler WM; Knauf LA; Hertzberg RC; Schoeny RS
Regul Toxicol Pharmacol; 1993 Dec; 18(3):392-402. PubMed ID: 8128001
[TBL] [Abstract][Full Text] [Related]
35. Quantification of variability and uncertainty for censored data sets and application to air toxic emission factors.
Zhao Y; Frey HC
Risk Anal; 2004 Aug; 24(4):1019-34. PubMed ID: 15357825
[TBL] [Abstract][Full Text] [Related]
36. Computation of profile likelihood-based confidence intervals for reference limits with covariates.
Virtanen A; Uusipaikka E
Stat Med; 2008 Mar; 27(7):1121-32. PubMed ID: 17674394
[TBL] [Abstract][Full Text] [Related]
37. Analysis of histamine release assays using the Bootstrap.
Coberly WA; Price JA
J Immunol Methods; 2005 Jan; 296(1-2):103-14. PubMed ID: 15680155
[TBL] [Abstract][Full Text] [Related]
38. Dose-response modeling of in vivo genotoxicity data for use in risk assessment: some approaches illustrated by an analysis of acrylamide.
Allen B; Zeiger E; Lawrence G; Friedman M; Shipp A
Regul Toxicol Pharmacol; 2005 Feb; 41(1):6-27. PubMed ID: 15649824
[TBL] [Abstract][Full Text] [Related]
39. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
40. Parametric bootstrap for testing model fitting in the proportional hazards framework: an application to the survival analysis of Bruna dels Pirineus beef calves.
Casellas J; Tarrés J; Piedrafita J; Varona L
J Anim Sci; 2006 Oct; 84(10):2609-16. PubMed ID: 16971560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
